compound
Retatrutide (30mg Vial) Questions Answered
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Retatrutide (30mg Vial)
Week(s) Weekly Dose (mcg) (mg) Units (per injection) (mL) Weeks 1–4 2,000 mcg (2 mg) 20 units (0.20 mL) Weeks 5–8 4,000 mcg (4 mg) 40 units (0.40 mL) Weeks 9–12 8,000 mcg (8 mg) 80 units (0.80 mL) Weeks 13+ 12,000 mcg (12 mg) 120 units (1.20 mL) — split int...
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Week(s) Weekly Dose (mcg) (mg) Units (per injection) (mL) Weeks 1–4 2,000 mcg (2 mg) 20 units (0.20 mL) Weeks 5–8 4,000 mcg (4 mg) 40 units (0.40 mL) Weeks 9–12 8,000 mcg (8 mg) 80 units (0.80 mL) Weeks 13+ 12,000 mcg (12 mg) 120 units (1.20 mL) — split int...
Plan based on a 12–48 week weekly protocol with gradual titration to maintenance dose.
Proper storage maintains peptide stability and potency. Lyophilized: Store at −20 °C (−4 °F) or colder for long-term preservation; protect from moisture and light [11] [12] .